Table 2.
Summary table of the meta-analysis.
| Study | year | Treatment | Sample size (M/F, n) | Mean/median age (years) | Tumor vascular invasion(Yes) | Number with large tumors(cut-off used; cm) | Number with Multiple primary tumors |
|---|---|---|---|---|---|---|---|
| Hashimoto et al23 | 2005 | S | 141(112/29) | 61.7 | 44 | NR | 56 |
| Nagaoka et al24 | 2007 | Multiple therapy | 90(68/22) | 65 | 12 | NR | NR |
| CHUN et al25 | 2010 | Multiple therapy | 56(48/8) | 55.7 | 14 | 40(>5) | 22 |
| Bertuzzo et al26 | 2011 | LT | 219(186/33) | 57 | 124 | NR | NR |
| Ishizuka et al27 | 2012 | S | 398(316/82) | 65.1 | 133 | 270(>2) | 98 |
| Kohles et al28 | 2012 | TACE | 38(32/6) | 67.9 | NR | 16 (>5) | 30 |
| Jang et al29 | 2012 | NS | 110(79/31) | 58.6 | 24 | 42(>5) | 56 |
| An et al30 | 2012 | LT | 85(64/21) | 53 | 22 | NR | 47 |
| Sieghart et al Aa,31 | 2012 | NS | 466(382/84) | 65 | 136 | 243(>5) | 187b |
| Sieghart et al Ba,31 | 2012 | TACE | 149(125/24) | 66 | 11 | 50(>5) | 64b |
| Kinoshita et al32 | 2012 | Multiple therapy | 133(95/38) | 71 | 13 | 37(≥5) | 66 |
| Hashimoto et al23 | 2005 | S | 141(112/29) | 61.7 | 44 | NR | 56 |
| Bertuzzo et al26 | 2011 | LT | 219(186/33) | 57 | 124 | NR | NR |
| Ho Jung An et al30 | 2012 | LT | 85(64/21) | 53 | 22 | NR | 47 |